Clinical Trials Directory

Trials / Conditions / Endometrial Mucinous Adenocarcinoma

Endometrial Mucinous Adenocarcinoma

8 registered clinical trials studyying Endometrial Mucinous Adenocarcinoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial
NCT05112601
National Cancer Institute (NCI)Phase 2
RecruitingDetermine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial
NCT05049538
M.D. Anderson Cancer Center—
CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance
NCT02020707
Mayo ClinicPhase 1
CompletedDalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
NCT01642082
Gynecologic Oncology GroupPhase 2
CompletedNintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer
NCT01225887
Gynecologic Oncology GroupPhase 2
CompletedDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
NCT01440998
National Cancer Institute (NCI)Phase 1
CompletedBrivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
NCT00888173
Gynecologic Oncology GroupPhase 2
UnknownRadiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
NCT00492778
GOG FoundationPhase 2